APYX vs EW · rev $48.1M vs P/E 47, rev $1.39B
Apyx Medical Inc (APYX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
APYX currently screens at market cap $179.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the APYX and EW stock pages for the full models.
Not investment advice.